Sanibel Captiva Trust Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.5M Buy
273,604
+3,356
+1% +$744K 1.67% 12
2025
Q4
$61.7M Buy
270,248
+1,981
+0.7% +$451K 1.71% 11
2025
Q3
$62.1M Buy
268,267
+1,144
+0.4% +$233K 1.77% 12
2025
Q2
$49.6M Buy
267,123
+2,515
+1% +$467K 1.52% 15
2025
Q1
$55.4M Buy
264,608
+8,527
+3% +$1.66M 1.8% 13
2024
Q4
$45.5M Buy
256,081
+349
+0.1% +$64.2K 1.45% 16
2024
Q3
$50.5M Sell
255,732
-3,567
-1% -$666K 1.62% 14
2024
Q2
$44.5M Sell
259,299
-6,967
-3% -$1.15M 1.52% 14
2024
Q1
$48.5M Sell
266,266
-4,686
-2% -$808K 1.65% 13
2023
Q4
$42M Buy
+270,952
New +$39.5M 1.55% 14

Other funds holding ABBV

Sanibel Captiva Trust Company's ABBV Position: Q1 2026 in Review

Sanibel Captiva Trust Company increased its AbbVie (ABBV) stake by 1.2% in Q1 2026, buying an estimated $744K and bringing the position to 273,604 shares worth $59.5M. The position accounts for 1.67% of the portfolio, ranked #12.

Sanibel Captiva Trust Company first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $62.1M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Sanibel Captiva Trust Company held 273,604 shares of AbbVie worth $59.5M as of Q1 2026.
  • Sanibel Captiva Trust Company bought 3,356 AbbVie shares in Q1 2026, an estimated $744K.
  • AbbVie made up 1.67% of Sanibel Captiva Trust Company's portfolio in Q1 2026, its #12 holding.
  • Sanibel Captiva Trust Company first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Sanibel Captiva Trust Company's AbbVie position peaked at $62.1M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q1 2026, filed 15 May 2026.